Group One Trading’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,000
| Closed | -$119K | – | 7217 |
|
|
2024
Q3 | $119K | Buy |
+2,000
| New | +$122K | ﹤0.01% | 4025 |
|
|
2024
Q2 | – | Sell |
-25,000
| Closed | -$1.73M | – | 6664 |
|
|
2024
Q1 | $1.73M | Buy |
+25,000
| New | +$1.51M | 0.01% | 1606 |
|
|
2023
Q4 | – | Sell |
-2,000
| Closed | -$116K | – | 7333 |
|
|
2023
Q3 | $116K | Hold |
2,000
| – | – | ﹤0.01% | 4319 |
|
|
2023
Q2 | $108K | Hold |
2,000
| – | – | ﹤0.01% | 4545 |
|
|
2023
Q1 | $79.4K | Buy |
+2,000
| New | +$84.3K | ﹤0.01% | 4499 |
|
|
2022
Q3 | – | Sell |
-500
| Closed | -$15K | – | 7501 |
|
|
2022
Q2 | $15K | Buy |
500
+300
| +150% | +$8.65K | ﹤0.01% | 6491 |
|
|
2022
Q1 | $6K | Hold |
200
| – | – | ﹤0.01% | 7354 |
|
|
2021
Q4 | $9K | Buy |
+200
| New | +$8.59K | ﹤0.01% | 7383 |
|
|
2020
Q1 | – | Sell |
-100
| Closed | -$6K | – | 5203 |
|
|
2019
Q4 | $6K | Sell |
100
-5,000
| -98% | -$331K | ﹤0.01% | 4706 |
|
|
2019
Q3 | $372K | Buy |
5,100
+4,900
| +2,450% | +$367K | ﹤0.01% | 2585 |
|
|
2019
Q2 | $16K | Buy |
+200
| New | +$14.2K | ﹤0.01% | 4255 |
|
|
2018
Q2 | – | Sell |
-2,500
| Closed | -$146K | – | 5056 |
|
|
2018
Q1 | $146K | Sell |
2,500
-2,200
| -47% | -$140K | ﹤0.01% | 3007 |
|
|
2017
Q4 | $303K | Buy |
4,700
+3,700
| +370% | +$230K | ﹤0.01% | 2638 |
|
|
2017
Q3 | $52K | Buy |
1,000
+400
| +67% | +$19.1K | ﹤0.01% | 3606 |
|
|
2017
Q2 | $28K | Sell |
600
-3,000
| -83% | -$145K | ﹤0.01% | 3809 |
|
|
2017
Q1 | $178K | Buy |
3,600
+2,400
| +200% | +$135K | ﹤0.01% | 2594 |
|
|
2016
Q4 | $73K | Sell |
1,200
-1,100
| -48% | -$67.3K | ﹤0.01% | 3022 |
|
|
2016
Q3 | $153K | Sell |
2,300
-3,000
| -57% | -$188K | ﹤0.01% | 2651 |
|
|
2016
Q2 | $296K | Sell |
5,300
-800
| -13% | -$38.9K | ﹤0.01% | 2138 |
|
|
2016
Q1 | $205K | Buy |
6,100
+5,100
| +510% | +$173K | ﹤0.01% | 2298 |
|
|
2015
Q4 | $45K | Buy |
+1,000
| New | +$43K | ﹤0.01% | 3468 |
|
|
2015
Q3 | – | Sell |
-100
| Closed | -$6K | – | 4829 |
|
|
2015
Q2 | $6K | Buy |
+100
| New | +$5.95K | ﹤0.01% | 4433 |
|
|
2013
Q4 | – | Sell |
-100
| Closed | -$1K | – | 5187 |
|
|
2013
Q3 | $1K | Buy |
+100
| New | +$721 | ﹤0.01% | 5020 |
|
Other funds holding ANIP
SCM
TCM
GACM
Group One Trading's ANIP Position: Q2 2026 in Review
Group One Trading sold out of ANI Pharmaceuticals (ANIP) in Q2 2026, closing a stake of 100 shares — an estimated $7.69K sold.
Group One Trading first reported a position in ANIP in Q2 2013 and held it in 13 quarters. The position peaked at $292K in Q3 2019. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.
- Group One Trading reported no remaining ANI Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Group One Trading sold 100 ANI Pharmaceuticals shares in Q2 2026, an estimated $7.69K.
- Group One Trading first reported a position in ANI Pharmaceuticals in Q2 2013 and held it in 13 quarters.
- Group One Trading's ANI Pharmaceuticals position peaked at $292K in Q3 2019.
- 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.